Klaim, a New York-based AI-driven healthcare payment acceleration solutions provider, has secured a strategic investment.  

Investors  

The investment was made directly by Claritev Corporation, a healthcare technology, data, and insights company dedicated to enhancing affordability, transparency, and quality across the healthcare system.  Leveraging world-class technology and AI, Claritev serves more than 700 healthcare payors, 100,000+ employers, 60 million consumers, and 1.4 million contracted providers.  

Klaim Use of Funds  

The investment will support the launch of a co-branded payment acceleration platform, integration of Klaim’s technology with Claritev’s ACE analytics, and scaling of operations across the U.S. and MENA regions.  

About Klaim  

Founded by Karim Dakki and Ghafoor Ahmad, Klaim is a healthcare-fintech company that provides a payment acceleration platform designed to improve cash flow efficiency for healthcare providers. Its proprietary AI-powered funding technology enables providers to accelerate insurance reimbursements and enhance cash flow predictability.  By converting pending claims into cash within 24 hours, Klaim helps healthcare organizations reduce administrative delays and strengthen financial resilience.  

Funding Details  

Company: Klaim, Inc.  

Raised: Undisclosed  

Round: Strategic Investment  

Funding Date: November 2025  

Lead Investor: Claritev Corporation  

Additional Investors:   

Company Website: https://klaim.com/  

Software Category: Healthcare Fintech / Payment Acceleration  

Source: https://www.businesswire.com/news/home/20251027220166/en/